A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials

by N. K. Hills, J. Lyimo, P. Nahid, R. M. Savic, C. Lienhardt, P. P. J. Phillips
Published 2021-08-01

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

by P Nahid, L G Jarlsberg, M Kato-Maeda, M R Segal, D H Osmond, S Gagneux, K Dobos, M Gold, P C Hopewell, D M Lewinsohn
Published 2018-01-01

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

by G.B. Sigal, M.R. Segal, A. Mathew, L. Jarlsberg, M. Wang, S. Barbero, N. Small, K. Haynesworth, J.L. Davis, M. Weiner, W.C. Whitworth, J. Jacobs, J. Schorey, D.M. Lewinsohn, P. Nahid
Published 2017-11-01